NeuroD1 Transcription Factor Converts Glial Cells to Neurons
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The central nervous system in mammals lacks the ability to regenerate itself following injury, with glial cells forming a dense scar tissue that prevents neuronal growth, and there is no method to reverse this scar for brain repair, necessitating a need for generating neurons in subjects with neurological conditions.
Innovation Solution
Expressing the exogenous NeuroD1 transcription factor in glial cells, such as astrocytes and NG2 cells, to convert them into functional neurons, using expression vectors like viral vectors, retroviruses, or retrovirus expression vectors, which results in the production of neuronal morphology, markers, electrophysiologic characteristics, synapse formation, and neurotransmitter release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If glial cells proliferate and form dense scar tissue following brain injury, then the injury site is protected and prevented from further damage, but neuronal growth is blocked and the central nervous system cannot regenerate
Solution Approach 1:
The patent converts the harmful effect of reactive glial cells and glial scar tissue into a beneficial outcome by using these same cells as a source material for generating new neurons. Instead of removing or suppressing the glial scar, the invention transdifferentiates glial cells within the scar into functional neurons, thereby eliminating the harmful blockage while preserving the protective role of the scar formation process.
Solution Approach 2:
The patent changes the phenotypic parameters of glial cells through the expression of specific transcription factors (such as NeuroD1, Ascl1, or Myt1l), transforming them from a glial state to a neuronal state. This parameter change allows the cells to maintain their location and structural role while acquiring neuronal functions, thus resolving the contradiction between scar protection and neuronal growth blockage.
2Stability of the object's composition
If the central nervous system maintains stability and prevents further damage after injury, then the existing neural structure is preserved, but the system lacks the ability to regenerate lost neurons
Solution Approach 1:
The patent enables the central nervous system to regenerate neurons using its own existing glial cells as the source material, without requiring external cell transplantation or complex external intervention. The glial cells within the nervous system itself are reprogrammed to become neurons, allowing the system to serve its own regenerative needs and overcome the historical limitation of neuronal irreversibility.
Solution Approach 2:
The patent performs the regenerative action by utilizing glial cells that have already proliferated and formed the scar tissue following injury. Instead of waiting for natural regeneration or attempting to reverse the scar formation process, the invention proactively transdifferentiates these pre-formed glial cells into neurons, converting the completed scar formation process into a productive regenerative outcome.
3Productivity
If reactive glial cells are eliminated or suppressed to allow neuronal growth, then neuronal regeneration can occur, but the protective function and structural support provided by glial cells is lost
Solution Approach 1:
The patent demonstrates that glial cells possess the latent potential to perform multiple functions - they can serve as structural support and protective elements in their glial state, and can be transformed into functional neurons when needed for regeneration. This multi-functionality allows the same cell population to provide both protective support and neuronal regeneration capabilities, resolving the contradiction between maintaining structural integrity and enabling neuronal growth.
Data Source
AI summary
Methods for producing new neurons in the brain in vivo are provided according to aspects of the present invention which include introducing NeuroD1 into a glial cell, particularly into a reactive astrocyte or NG2 cell, thereby “converting” the reactive glial cell to a neuron. Methods of producing a neuronal phenotype in a glial cell are provided according to aspects of the present invention which include expressing exogenous NeuroD1 in the glial cell, wherein expressing exogenous NeuroD1 includes delivering an expression vector, such as a viral expression vector, including a nucleic acid encoding the exogenous NeuroD1 to the glial cell.